Company intelligence / Profile preview

Radformation

New York City, New York, United Statesradformation.com ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Radformation’s FDA-cleared software automates and optimizes the treatment planning process in radiation oncology. Its products are used by over 2000 clinics globally to improve plan quality, safety, efficiency, and reduce errors in cancer care. The company has demonstrated rapid adoption since its founding in 2016.

Therapeutic areas: Oncology
Modalities: DeviceNon-pharmacological therapyArtificial intelligence software
Industry: Digital Health Medical Devices

Partnerships

Icon Group

Beyond the preview

Go deeper on Radformation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Radformation.

Explore the full profile